BDNF Cancer Research Results
BDNF, brain-derived neurotrophic factor: Click to Expand ⟱
| Source: |
| Type: |
Brain-Derived Neurotrophic Factor (BDNF) is a key neurotrophin (a type of growth factor) involved in brain health, and its role in Alzheimer’s Disease (AD) has been extensively studied.
-AD patients often have lower BDNF levels in key brain regions, such as the hippocampus and cortex.
-This reduction correlates with cognitive decline and brain atrophy.
-BDNF normally protects neurons from Aβ toxicity
-Exercise and cognitive training have been shown to boost BDNF levels and may slow cognitive decline.
- natural compounds (like curcumin or flavonoids) may also upregulate BDNF.
|
Nor, Normal Healthy: Click to Expand ⟱
Scientific Papers found: Click to Expand⟱
| - |
in-vitro, |
BC, |
MDA-MB-231 |
|
|
|
- |
in-vitro, |
Nor, |
MCF10 |
|
|
|
TumCP↓, TumCMig↓, selectivity↑, *BDNF↑, *ROS↓, *TNF-α↓, *IL6↓, *IFN-γ↓, *NF-kB↓, BAX⇅, Bcl-2↓, *antiOx↑, radioP↑, ChemoSen↑,
| - |
Review, |
Nor, |
NA |
|
|
|
- |
Review, |
IBD, |
NA |
|
|
|
- |
Review, |
AD, |
NA |
|
|
|
*Inflam↓, *antiOx↑, *hepatoP↑, *lipid-P↓, *TNF-α↓, *ICAM-1↓, *IL1β↓, *IL6↓, *MUC1↑, *OCLN↑, *IBI↑, *ROS↓, *cardioP↑, *SOD↑, *GPx↑, *GSH↑, *TG/TAG↓, *LDL↓, *neuroP↑, *5HT↑, *BDNF↑,
*Sleep↑, *BDNF↑,
| - |
Review, |
Nor, |
NA |
|
|
|
- |
Review, |
Stroke, |
NA |
|
|
|
- |
Review, |
Park, |
NA |
|
|
|
*antiOx↑, *ROS↓, *neuroP↑, *NO↑, BioAv↝, *BBB↑, *toxicity↑, *eff↑, *GSH↑, *SOD↑, *Aβ↓, *12LOX↓, *COX2/PTGS2↓, *Catalase↑, *Inflam↓, *TNF-α↓, *IL6↑, *lipid-P↓, NF-kB↓, IL1β↓, NRF2↑, HO-1↑, GSTs↑, cognitive↑, *BDNF↑,
*ROS↓, *p‑Akt↓, *p‑mTOR↓, *p‑p70S6↓, *BDNF↑, *Apoptosis↓, *Casp3↓, *Bcl-2↑,
| - |
Review, |
Nor, |
NA |
|
|
|
- |
Review, |
AD, |
NA |
|
|
|
*RenoP↓, Casp3↑, Casp8↑, MDA↑, GSH↓, SOD↓, Catalase↓, VEGF↓, Bcl-2↓, TumCG↓, p‑Akt↓, PI3K↓, TumCCA↑, TumCP↓, BMP7/OP1↓, *ZO-1↑, *BBB↝, *p‑Akt↑, *GSK‐3β↑, *SOD↑, *Catalase↑, *GSH↑, *SIRT1↑, *NF-kB↓, *IL1β↓, *IL6↓, *IL8↓, *TNF-α↓, *ROS↓, *MDA↓, *BAX↓, *Casp3↓, *Bcl-2↑, *BDNF↑, *TrkB↑, *NGF↑, *Apoptosis↓, *cardioP↑, *AST↓, *hepatoP↑, *AST↓, *ALAT↓, *MDA↓, *BACH1↓, *neuroP↑, *Stroke↓, *ICAM-1↓, *VCAM-1↓, *TLR4↓, *COX2/PTGS2↓, *RenoP↑, *NLRP3↓, *Casp1↓, *ASC↓, *BioAv↓, *BioAv↑, *toxicity↓,
*BDNF↑, *motorD↑, *Diff↑,
| - |
in-vitro, |
Nor, |
SH-SY5Y |
|
|
|
- |
in-vitro, |
AD, |
NA |
|
|
|
*cognitive↑, *ROS↓, *BDNF↑, *neuroP↑, *antiOx↑,
*NRF2↑, *HO-1↑, *NGF↑, *BDNF↑, *neuroP↑, p‑CREB↑,
| - |
in-vivo, |
Nor, |
NA |
|
|
|
- |
NA, |
Stroke, |
NA |
|
|
|
*neuroP↑, *p‑PTEN↓, *p‑Akt↑, *Bcl-2↑, *BAX↓, *cognitive↑, *BDNF↑,
| - |
Review, |
Nor, |
NA |
|
|
|
- |
Review, |
AD, |
NA |
|
|
|
- |
Review, |
Park, |
NA |
|
|
|
*ROS↓, *Inflam↓, TumCG↓, *neuroP↑, *cardioP↑, *LDL↓, *BioAv↝, *BioAv↓, *BioAv↑, *SIRT1↑, *mTOR↑, *BDNF↑, *cognitive↑,
Showing Research Papers: 1 to 11 of 11
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 11
Pathway results for Effect on Cancer / Diseased Cells:
NA, unassigned(tgid=0) ⓘ
BMP7/OP1↓, 1,
Redox & Oxidative Stress(tgid=1) ⓘ
Catalase↓, 1, GSH↓, 1, GSTs↑, 1, HO-1↑, 1, MDA↑, 1, NRF2↑, 1, SOD↓, 1,
Core Metabolism/Glycolysis(tgid=4) ⓘ
p‑CREB↑, 1,
Cell Death(tgid=5) ⓘ
p‑Akt↓, 1, BAX⇅, 1, Bcl-2↓, 2, Casp3↑, 1, Casp8↑, 1,
Cell Cycle & Senescence(tgid=11) ⓘ
TumCCA↑, 1,
Proliferation, Differentiation & Cell State(tgid=12) ⓘ
PI3K↓, 1, TumCG↓, 2,
Migration(tgid=13) ⓘ
TumCMig↓, 1, TumCP↓, 2,
Angiogenesis & Vasculature(tgid=14) ⓘ
VEGF↓, 1,
Immune & Inflammatory Signaling(tgid=16) ⓘ
IL1β↓, 1, NF-kB↓, 1,
Drug Metabolism & Resistance(tgid=21) ⓘ
BioAv↝, 1, ChemoSen↑, 1, selectivity↑, 1,
Functional Outcomes(tgid=23) ⓘ
cognitive↑, 1, radioP↑, 1,
Total Targets: 27
Pathway results for Effect on Normal Cells:
NA, unassigned(tgid=0) ⓘ
Stroke↓, 1,
Redox & Oxidative Stress(tgid=1) ⓘ
antiOx↑, 4, Catalase↑, 2, GPx↑, 1, GSH↑, 3, HO-1↑, 1, lipid-P↓, 2, MDA↓, 2, NRF2↑, 1, ROS↓, 7, SOD↑, 3,
Core Metabolism/Glycolysis(tgid=4) ⓘ
12LOX↓, 1, ALAT↓, 1, LDL↓, 2, SIRT1↑, 2,
Cell Death(tgid=5) ⓘ
p‑Akt↓, 1, p‑Akt↑, 2, Apoptosis↓, 2, BAX↓, 2, Bcl-2↑, 3, Casp1↓, 1, Casp3↓, 2,
Kinase & Signal Transduction(tgid=6) ⓘ
p‑p70S6↓, 1,
Proliferation, Differentiation & Cell State(tgid=12) ⓘ
Diff↑, 1, GSK‐3β↑, 1, mTOR↑, 1, p‑mTOR↓, 1, p‑PTEN↓, 1,
Migration(tgid=13) ⓘ
BACH1↓, 1, MUC1↑, 1, VCAM-1↓, 1, ZO-1↑, 1,
Angiogenesis & Vasculature(tgid=14) ⓘ
NO↑, 1,
Barriers & Transport(tgid=15) ⓘ
BBB↑, 1, BBB↝, 1, IBI↑, 1, OCLN↑, 1,
Immune & Inflammatory Signaling(tgid=16) ⓘ
ASC↓, 1, COX2/PTGS2↓, 2, ICAM-1↓, 2, IFN-γ↓, 1, IL1β↓, 2, IL6↓, 3, IL6↑, 1, IL8↓, 1, Inflam↓, 3, NF-kB↓, 2, TLR4↓, 1, TNF-α↓, 4,
Synaptic & Neurotransmission(tgid=18) ⓘ
5HT↑, 1, BDNF↑, 11, NGF↑, 2, TrkB↑, 1,
Protein Aggregation(tgid=19) ⓘ
Aβ↓, 1, NLRP3↓, 1,
Drug Metabolism & Resistance(tgid=21) ⓘ
BioAv↓, 2, BioAv↑, 2, BioAv↝, 1, eff↑, 1,
Clinical Biomarkers(tgid=22) ⓘ
ALAT↓, 1, AST↓, 2, IL6↓, 3, IL6↑, 1, TG/TAG↓, 1,
Functional Outcomes(tgid=23) ⓘ
cardioP↑, 3, cognitive↑, 3, hepatoP↑, 2, motorD↑, 1, neuroP↑, 7, RenoP↓, 1, RenoP↑, 1, Sleep↑, 1, toxicity↓, 1, toxicity↑, 1,
Total Targets: 74
Scientific Paper Hit Count for: BDNF, brain-derived neurotrophic factor
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:49 Cells:% prod#:% Target#:1356 State#:% Dir#:2
wNotes=0 sortOrder:rid,rpid
Home Page